The effect of registration surrogate and patient factors on the interobserver variability of electronic portal image guidance during prostate radiotherapy

Medical Dosimetry

Volumn 36, Issue 4, 2011, Pages 337-343

  Kong, Vickie ^a   Lockwood, Gina ^a   Yan, Jing ^a   Catton, Charles ^a   Chung, Peter ^a   Bayley, Andrew ^a   Rosewall, Tara ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Electronic portal image; Image alignment; Interobserver variability; Intraprostatic fiducial marker

Indexed keywords

ACCURACY; ARTICLE; BODY MOVEMENT; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DIGITAL RADIOGRAPHY; ELECTRONIC PORTAL IMAGING; FIDUCIAL MARKER; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IMAGING; MALE; OBSERVER VARIATION; PATIENT FACTOR; PELVIC GIRDLE; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RADIOLOGICAL PARAMETERS; REGISTRATION SURROGATE; REPRODUCIBILITY;

FIDUCIAL MARKERS; HUMANS; MALE; MOVEMENT; PELVIC BONES; PROSTATE; PROSTATIC NEOPLASMS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SOFTWARE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80755172741     PISSN: 09583947     EISSN: 18734022     Source Type: Journal    
DOI: 10.1016/j.meddos.2010.07.005     Document Type: Article

References (37)

1. Bucci M.K., Bevan A., Roach M. Advances in radiation therapy: Conventional to 3D, to IMRT, to 4D, and beyond. CA. Cancer. J. Clin. 2005, 55:117-134.
2. Wertz H., Lohr F., Dobler B., et al. [Dosimetric impact of image-guided translational isocenter correction for 3-D conformal radiotherapy of the prostate]. Strahlenther. Onkol. 2007, 183:203-210.
3. Dawson L.A., Jaffray D.A. Advances in image-guided radiation therapy. J. Clin. Oncol. 2007, 25:938-946.
4. Kitamura K., Shirato H., Shimizu S., et al. Registration accuracy and possible migration of internal fiducial gold marker implanted in prostate and liver treated with real-time tumor-tracking radiation therapy (RTRT). Radiother. Oncol. 2002, 62:275-281.
5. Poggi M.M., Gant D.A., Sewchand W., et al. Marker seed migration in prostate localization. Int. J. Radiat. Oncol. Biol. Phys. 2003, 56:1248-1251.
6. Shirato H., Harada T., Harabayashi T., et al. Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2003, 56:240-247.
7. Kupelian P.A., Willoughby T.R., Meeks S.L., et al. Intraprostatic fiducials for localization of the prostate gland: Monitoring intermarker distances during radiation therapy to test for marker stability. Int. J. Radiat. Oncol. Biol. Phys. 2005, 62:1291-1296.
8. Nichol A.M., Brock K.K., Lockwood G.A., et al. A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers. Int. J. Radiat. Oncol. Biol. Phys. 2006, 67:48-56.
9. Chung P.W., Haycocks T., Brown T., et al. On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2004, 60:329-334.
10. Litzenberg D.W., Balter J.M., Lam K.L., et al. Retrospective analysis of prostate cancer patients with implanted gold markers using off-line and adaptive therapy protocols. Int. J. Radiat. Oncol. Biol. Phys. 2005, 63:123-133.
11. Schallenkamp J.M., Herman M.G., Kruse J.J., et al. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int. J. Radiat. Oncol. Biol. Phys. 2005, 63:800-811.
12. Vetterli D., Thalmann S., Behrensmeier F., et al. Daily organ tracking in intensity-modulated radiotherapy of prostate cancer using an electronic portal imaging device with a dose saving acquisition mode. Radiother. Oncol. 2006, 79:101-108.
13. de Boer H.C., van Os M.J., Jansen P.P., et al. Application of the No Action Level (NAL) protocol to correct for prostate motion based on electronic portal imaging of implanted markers. Int. J. Radiat. Oncol. Biol. Phys. 2005, 61:969-983.
14. Moseley D.J., White E.A., Wiltshire K.L., et al. Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 2007, 67:942-953.
15. Fuller C.D., Thomas C.R., Schwartz S., et al. Method comparison of ultrasound and kilovoltage x-ray fiducial marker imaging for prostate radiotherapy targeting. Phys. Med. Biol. 2006, 51:4981-4993.
16. Langen K.M., Zhang Y., Andrews R.D., et al. Initial experience with megavoltage (MV) CT guidance for daily prostate alignments. Int. J. Radiat. Oncol. Biol. Phys. 2005, 62:1517-1524.
17. Bissett R., Boyko S., Leszczynski K., et al. Radiotherapy portal verification: An observer study. Br. J. Radiol. 1995, 68:165-174.
18. Thomason C. User introduced uncertainties in the measurement of field misalignment by a computer aided technique. Med. Dosim. 1998, 23:278-283.
19. Perera T., Moseley J., Munro P. Subjectivity in interpretation of portal films. Int. J. Radiat. Oncol. Biol. Phys. 1999, 45:529-534.
20. Matsopoulos G.K., Asvestas P.A., Delibasis K.K., et al. Registration of electronic portal images for patient set-up verification. Phys. Med. Biol. 2004, 49:3279-3289.
21. Lewis D.G., Ryan K.R., Smith C.W. Observer variability when evaluating patient movement from electronic portal images of pelvic radiotherapy fields. Radiother. Oncol. 2005, 74:275-281.
22. Berthelet E., Truong P.T., Zavgorodni S., et al. Consistency in electronic portal imaging registration in prostate cancer radiation treatment verification. Radiat. Oncol. 2006, 1:37.
23. Ullman K.L., Ning H., Susil R.C., et al. Intra- and inter-radiation therapist reproducibility of daily isocenter verification using prostatic fiducial markers. Radiat. Oncol. 2006, 1:2.
24. Budiharto T., Slagmolen P., Hermans J., et al. A semi-automated 2D/3D marker-based registration algorithm modelling prostate shrinkage during radiotherapy for prostate cancer. Radiother. Oncol. 2009, 90:331-336.
25. Nichol A.M., Rosewall T., Catton C.N., et al. Intra-prostatic fiducial markers and concurrent androgen deprivation. Clin. Oncol. (R. Coll. Radiol.) 2005, 17:465-468.
26. Huda W., Scalzetti E.M., Levin G., et al. Technique factors and image quality as functions of patient weight at abdominal CT. Radiology 2000, 217:430-435.
27. Wu J., Haycocks T., Alasti H., et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother. Oncol. 2001, 61:127-133.
28. Antolak J.A., Rosen I.I., Childress C.H., et al. Prostate target volume variations during a course of radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1998, 42:661-672.
29. Shrout P.E., Fleiss J.L. Intraclass correlations: Uses in assessing rater reliability. Psychol. Bull. 1979, 86:420-428.
30. Bland J.M., Altman D.G. Measuring agreement in method comparison studies. Stat. Methods. Med. Res. 1999, 8:135-160.
31. Kudchadker R.J., Lee A.K., Yu Z.H., et al. Effectiveness of using fewer implanted fiducial markers for prostate target alignment. Int. J. Radiat. Oncol. Biol. Phys. 2009, 74:1283-1289.
32. Foulkes K.M., Ostwald P.M., Kron T. A clinical comparison of different film systems for radiotherapy portal imaging. Med. Dosim. 2001, 26:281-284.
33. French J., Darud M., Mitchell F., et al. The use of clinical audit to monitor the transfer of responsibility for verification of electronic portal images. Can. J. Med. Radiat. Technol.. summer 2006, 18-22.
34. Holden L., Loblaw A. Prospective evaluation of the concordance between radiation therapists and radiation oncologists on daily verification films. Can. J. Med. Radiat. Technol. 2005, 36:20-24.
35. Suter B., Shoulders B., Maclean M., et al. Machine verification radiographs: An opportunity for role extension?. Radiography. 2000, 6:245-251.
36. Nederveen A.J., Dehnad H., van der Heide U.A., et al. Comparison of megavoltage position verification for prostate irradiation based on bony anatomy and implanted fiducials. Radiother. Oncol. 2003, 68:81-88.
37. Herman M.G., Pisansky T.M., Kruse J.J., et al. Technical aspects of daily online positioning of the prostate for three-dimensional conformal radiotherapy using an electronic portal imaging device. Int. J. Radiat. Oncol. Biol. Phys. 2003, 57:1131-1140.